A discussion between our CEO + University of Oxford’s Sarah Gilbert | Ferrovial

Our CEO, Ignacio Madridejos, sat down with Sarah Gilbert, one of the researchers who is leading the development of the COVID-19 vaccine at the University of Oxford. They discussed the vaccine in-depth and how our donation of €500,000 is helping them in their research. This donation was part of our #FerrovialTogetherCOVID19 fund.